Clinical Trial Update: A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0123-0338 in Healthy Subjects and in Subjects With Type 1 Diabetes Mellitus [Phase 1]

View source ↗

Summary

This clinical trial update documents a Phase 1 study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous NNC0123-0338 in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NNC0123-0338 (NNC0123-0338)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Healthy, Diabetes | Phase 1 | Status: COMPLETED